Cargando…

636. Meningococcal Vaccination and Antibiotic Prophylaxis Practices in Solid Organ Transplant Recipients undergoing Eculizumab Therapy

BACKGROUND: Eculizumab, an inhibitor of terminal complement activation, has been utilized in pre-transplant desensitization, treatment of antibody-mediated rejection and thrombotic microangiopathy in solid organ transplant recipients (SOTR). Eculizumab is associated with meningococcal disease, leadi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhaimia, Eric, Yetmar, Zachary A, Mahmood, Maryam, Stacy, Bernard, Stephen, Jenise, Vikram, Holenarasipur R, Brumble, Lisa M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752852/ http://dx.doi.org/10.1093/ofid/ofac492.688

Ejemplares similares

1086. Epidemiology, Risk Factors, and Effect of Antifungal Prophylaxis on Early Invasive Fungal Infection in Heart Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2020)

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)

Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan
por: Tanimoto, Tetsuya, et al.
Publicado: (2014)

1233. Serious Toxicities During Antimicrobial Therapy for Disseminated Nocardia Infection in Solid Organ Transplant Recipients
por: Saling, Christopher, et al.
Publicado: (2021)

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
por: McNamara, Lucy A., et al.
Publicado: (2017)

462 Impact of Pre-transplant LVAD Therapy on Survival and Infectious Complications in Heart Transplant Recipients
por: Arif, Sana, et al.
Publicado: (2014)

Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States
por: Bozio, Catherine H., et al.
Publicado: (2020)

Long-term Use of Eculizumab in Kidney Transplant Recipients
por: Milan Manani, Sabrina, et al.
Publicado: (2018)

Estudios de pequeña velocidad Op. 636
por: Czerny, Carl, 1791-1857
Publicado: (1994)

A Kidney Transplant Recipient on Prophylactic Eculizumab Presenting With Myalgia
por: Shivakumar, Oshini, et al.
Publicado: (2022)

2715. Toxicities and clinical consequences of valganciclovir prophylaxis in solid organ transplant recipients
por: Lahoud, Chloe, et al.
Publicado: (2023)

Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database
por: Matsumura, Yumi
Publicado: (2020)

24 Studi della piccola velocita Op. 636 : per pianoforte
por: Czerny, Karl, 1791-1857
Publicado: (1949)

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
por: Cheung, Chee Kay, et al.
Publicado: (2019)

Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome
por: Durán, Carlos E., et al.
Publicado: (2012)

FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
por: Varma, Madhu, et al.
Publicado: (2023)

Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients
por: Peleg, Anton Y., et al.
Publicado: (2009)

Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
por: Yetmar, Zachary A, et al.
Publicado: (2022)

636. The Hepcidin-25 and Iron Kinetics During the Acute Phase of Systemic Infection
por: Moro, Hiroshi, et al.
Publicado: (2018)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
por: Wijnsma, Kioa Lente, et al.
Publicado: (2019)

Analysis of a meningococcal meningitis outbreak in Niger – potential effectiveness of reactive prophylaxis
por: Hitchings, Matt D. T., et al.
Publicado: (2019)

Interleukin-6 (-636 C/G) Gene Polymorphism in Korean Children With Kawasaki Disease
por: Ahn, Hye Mi, et al.
Publicado: (2011)

The Influence of the I7 Experimental Magnets on the Beams, Runs 631, 636, 646, 662
por: Hoffmann, H
Publicado: (1976)

636. Epidemiology and Outcome Among the Elderly Hospitalized Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

Eculizumab Dosing in Infants
por: Kobrzynski, M., et al.
Publicado: (2018)

Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report
por: Attieh, Rose Mary, et al.
Publicado: (2023)

2402. Evaluating Clinical Outcomes of Adjunctive Beta-Lactam Use in Vancomycin-Resistant Enterococcus Infective Endocarditis
por: Khan, Ebrahim H, et al.
Publicado: (2023)

1429. Meningococcal Disease Outbreak in a Refugee Reception Identification Center in Greece and Administration of Mass Antibiotic Prophylaxis
por: Magaziotou, Ioanna, et al.
Publicado: (2020)

Nutrient Intake in Italian Infants and Toddlers from North and South Italy: The Nutrintake 636 Study
por: Zuccotti, Gian Vincenzo, et al.
Publicado: (2014)

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir
por: Morishita, Asahiro, et al.
Publicado: (2018)

miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2019)

SAT636 Obesity And Aging Interactions Modify The Breast Tissue Microbiome Influencing Cancer Risk
por: Iyengar, Neil M, et al.
Publicado: (2023)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
por: Mizuno, Kana, et al.
Publicado: (2022)

545. A Retrospective Review of 30-day Mortalities in Solid-Organ Transplant Recipients (SOT) versus Non-Transplant Patients (NTP) Receiving Remdesivir (REM) and Dexamethasone (DEX) for COVID-19 Pneumonia
por: Vyas, Krina, et al.
Publicado: (2021)

1702. Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis
por: Yee, Jason, et al.
Publicado: (2020)

Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS
por: Favi, Evaldo, et al.
Publicado: (2022)

Eculizumab as rescue therapy in a kidney transplant recipient with atypical hemolytic uremic syndrome: a case report
por: Oh, Young Ju, et al.
Publicado: (2022)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_2h3j90uprbtbodtuj3oi1j3hn5